US Edition
Poolbeg Pharma PLC (AIM:POLB) Proposed Fundraising to raise approximately £4.1M
Summary by Share Talk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Poolbeg Pharma PLC (AIM:POLB) Proposed Fundraising to raise approximately £4.1M
Proposed Fundraising to raise approximately £4.1 million Launch of Placing via accelerated bookbuild and Notice of General Meeting Poolbeg Pharma plc (AIM: POLB), a clinical-stage biopharmaceutical company focussed on the developmentRead More...
Poolbeg Pharma plc – Results for the year ended 31 December 2024 – Optimum Strategic CommunicationsLink to: Lars Rebien Sørensen to join the board of directors of Novo Nordisk A/SLink to: Poolbeg Pharma plc – Proposed Fundraising to raise approximately £4
20 May 2025- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces its audited results for the year ended 31 December 2024. Read more…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
